Given a paragraph, generate a claim that is supported by the given paragraph. 1) The claim must contain information from within the paragraph. 2) A sentence within the paragraph can be used as a claim. 3) The claim should not have contradictions within the paragraph. 4) The claim should be at most one sentence long.

Ex Input:
Under the agreement, Emergent BioSolutions will no longer enforce a contract that had allowed it to be the only company to develop a nasal spray version of the drug nalmefene for use as an antidote in a nasal spray. The attorney general’s office said the new agreement came after it found that Adapt Pharma, which has since been bought by Rockville, Maryland-based Emergent, had the exclusive rights to sell the drug using Aptar Pharma’s nasal spray technology. The drug is still in the pipeline and is not on the market, though. “Given the tragic, devastating effects of the opioid crisis, and the urgent need for additional drugs for the emergency treatment of opioid overdoses, my office will do whatever possible to ensure that there are no unnecessary impediments to the development of additional life-saving opioid overdose reversal drugs,” Attorney General Letitia James said in a written statement. The agreement with James’s office does not affect Narcan, a spray version of the drug naloxone now sold by Emergent. That from is popular for police, firefighters and others to use to try to revive people who are overdosing. It is not subject to an exclusivity agreement on the spray technology. Narcan retails for about $140 for two doses, but the company sells that amount to first responders for $75. More than 400,000 deaths in the U.S. since 2000 have been linked to opioids, a class of drugs that includes heroin, fentanyl, and prescription painkillers such as Vicodin and OxyContin. Companies would still need Food and Drug Administration approval before their products could be on the market. There is at least one effort to introduce a generic version of a naloxone nasal spray. Purdue Pharma, the maker of OxyContin, announced a grant in 2018 for a nonprofit drug company to develop one. ___ This story has been updated to correct that the drug at the center of the agreement is a spray version of nalmefene that is under development, not naloxone. It also clarifies that Narcan is sold to first responders for a lower-than-retail price.

Ex Output:
Deal will let more companies make an overdose antidote spray.


Ex Input:
"In his address to a joint session of Congress, President Barack Obama brought up the most explosive charge to emerge in the health care debate: the specter of ""death panels."" ""Some of people’s concerns (about the health care legislation) have grown out of bogus claims spread by those whose only agenda is to kill reform at any cost,"" Obama told lawmakers and a national television audience on Sept. 9, 2009. ""The best example is the claim, made not just by radio and cable talk show hosts, but by prominent politicians, that we plan to set up panels of bureaucrats with the power to kill off senior citizens. Now, such a charge would be laughable if it weren’t so cynical and irresponsible. It is a lie, plain and simple."" The president was referring to a notion most prominently raised by former Alaska Republican Gov. Sarah Palin in a note posted on her Facebook page on Aug. 7, 2009. ""And who will suffer the most when they ration care?"" Palin wrote. ""The sick, the elderly, and the disabled, of course. The America I know and love is not one in which my parents or my baby with Down Syndrome will have to stand in front of Obama's 'death panel' so his bureaucrats can decide, based on a subjective judgment of their 'level of productivity in society,' whether they are worthy of health care. Such a system is downright evil."" We have read all 1,000-plus pages of the Democratic bill and examined versions in various committees. There is no panel in any version of the health care bills in Congress that judges a person's ""level of productivity in society"" to determine whether someone is ""worthy"" of health care. When we first  assessed  Palin's claim on Aug. 7, 2009, we gave it our lowest rating — . Palin may have jumped to a conclusion about the Obama administration's efforts to promote comparative effectiveness research. Such research has nothing to do with evaluating patients for ""worthiness."" Rather, comparative effectiveness research finds out which treatments work better than others. The health reform bill being considered in the House of Representatives says that a Comparative Effectiveness Research Center shall ""conduct, support, and synthesize research"" that looks at ""outcomes, effectiveness, and appropriateness of health care services and procedures in order to identify the manner in which diseases, disorders, and other health conditions can most effectively and appropriately be prevented, diagnosed, treated, and managed clinically."" The idea here, which Obama and his budget director Peter Orszag have discussed many times, is to make it easier for doctors, health care workers, insurance companies and patients to find out which treatments are the most effective, as determined by clinical studies and other research. The House bill states in the section creating the Comparative Effectiveness Research Center and an oversight commission that ""nothing in this section shall be consd to permit the Commission or the Center to mandate coverage, reimbursement, or other policies for any public or private payer."" In other words, comparative effectiveness research will tell you whether treatment A is better than treatment B. But the bill as written won't mandate which treatment doctors and patients have to select. Nothing has emerged to suggest to us that the death panels claim is any more  today than it was when Palin first floated it. We still rate it as  today. In our book, that counts as a ""lie, plain and simple."" So we find Obama's claim ."

Ex Output:
The claim ... that we plan to set up panels of bureaucrats with the power to  kill off senior citizens ... is a lie, plain and simple.


Ex Input:
The government has tested around 83,000 people so far for COVID-19, the respiratory disease caused by the virus, Canada’s deputy chief public health officer Howard Njoo told reporters. There have been 1,099 confirmed cases. Canada has taken several measures to contain the fast-spreading virus, including closing its border with the United States, which came into effect on Friday night. Trudeau, who is himself in self-isolation after his wife tested positive for COVID-19, told reporters on Saturday the government is ramping up testing to detect as many cases as possible. “The ramping up of testing is increasing at a tremendous pace.... we are getting more equipment for testing. We recognize that broad scale testing is an essential tool in continuing to fight the spread of this disease,” Trudeau told reporters. There are around 5,000 ventilators across the country, Njoo said. He also said Canada is making efforts to bring home stranded citizens, and an Air Canada (AC.TO) plane is in the process of repatriating citizens from Morocco. He named Peru and Spain as two potential countries from which Canada was working with airlines to bring home stranded citizens. But Trudeau said the travel restriction put in place by many countries mean not every Canadian stuck overseas would be able to come home immediately. “We are going to ask people to stay safe, make smart choices and do the best they can in a situation that is unprecedented, exceptional and very difficult,” Trudeau said. Canada’s foreign minister François-Philippe Champagne estimated there are ten of thousands of Canadians overseas. Trudeau’s government has pledged C$27 billion ($18.6 billion) to help the economy amid the virus outbreak, which could blow out the fiscal deficit and lead to higher government borrowing by nearly 40%, according to Reuters calculations. “We have heard a wide range of estimates from economists and  banks about how bad it is going to get. The only thing they seem to agree on is, it is going to get very bad. Fortunately, Canada is in an extremely strong fiscal position... and that gives us room to inject money into people’s pocket,” Trudeau added. Meanwhile, Canada’s decision to turn back asylum seekers who walk over the U.S.-Canada border has been criticized by advocates. “The government’s decision... ignores the recommendations of the World Health Organization and isn’t part of a sound pandemic management plan,” said Nazila Bettache, with the Caring for Social Justice Collective. She said asylum seekers will cross by other means that are less controlled and will not have access to proper safety measures, such as a 14-day quarantine.

Ex Output:

Canada's coronavirus death toll rises to 13 as repatriation efforts step up.